About Uni Schleswig-Holstein; Klinik für Dermatologie, Allergologie und Venerologie (Hautklinik)
Clinical Trials at Uni Schleswig-Holstein; Klinik für Dermatologie, Allergologie und Venerologie (Hautklinik)
During the past decade, Uni Schleswig-Holstein; Klinik für Dermatologie, Allergologie und Venerologie (Hautklinik) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Uni Schleswig-Holstein; Klinik für Dermatologie, Allergologie und Venerologie (Hautklinik)"
#1 collaborator was "BioNTech SE" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Uni Schleswig-Holstein; Klinik für Dermatologie, Allergologie und Venerologie (Hautklinik)
According to Clinical.Site data, the most researched conditions in "Uni Schleswig-Holstein; Klinik für Dermatologie, Allergologie und Venerologie (Hautklinik)" are
"Advanced Melanoma" (1 trials), "Basal Cell Carcinoma" (1 trials), "Malignant Melanoma" (1 trials) and "Melanoma" (1 trials). Many other conditions were trialed in "Uni Schleswig-Holstein; Klinik für Dermatologie, Allergologie und Venerologie (Hautklinik)" in a lesser frequency.
Clinical Trials Intervention Types at Uni Schleswig-Holstein; Klinik für Dermatologie, Allergologie und Venerologie (Hautklinik)
Most popular intervention types in "Uni Schleswig-Holstein; Klinik für Dermatologie, Allergologie und Venerologie (Hautklinik)" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (1 trials), "Atezolizumab Placebo" (1 trials), "Cobimetinib" (1 trials), "Pembrolizumab" (1 trials) and "RO7198457" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Uni Schleswig-Holstein; Klinik für Dermatologie, Allergologie und Venerologie (Hautklinik)
The vast majority of trials in "Uni Schleswig-Holstein; Klinik für Dermatologie, Allergologie und Venerologie (Hautklinik)" are
4 trials for "All" genders.
Clinical Trials Status at Uni Schleswig-Holstein; Klinik für Dermatologie, Allergologie und Venerologie (Hautklinik)
Currently, there are NaN active trials in "Uni Schleswig-Holstein; Klinik für Dermatologie, Allergologie und Venerologie (Hautklinik)".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Uni Schleswig-Holstein; Klinik für Dermatologie, Allergologie und Venerologie (Hautklinik),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Uni Schleswig-Holstein; Klinik für Dermatologie, Allergologie und Venerologie (Hautklinik), 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".